Delivery Order SPE2DB24D3014-SPE2DB25FKUSH
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,951.95 for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,059.92 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,397.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and was competitively awarded without set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,477.80 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen 0.5 mL, a diabetes medication, on May 12, 2025, with an ultimate completion date of May 13, 2025. The contract employs firm fixed-price pricing under a competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the awardee with performance occurring at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency awarded a delivery order valued at $1,154.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This non-competitive delivery order, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, was awarded under firm fixed pricing terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location in the same city. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,260.67 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.14 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed-price contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,663.27 for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with performance to be executed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,478.24 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,075.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract, awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-competitive, competitively awarded transaction under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUSHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication. This is a firm fixed price, non-competitive delivery order under an Indefinite Delivery Contract (IDC) with a completion date of September 18, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The parent contract enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a critical vendor in the federal medical procurement landscape, AmerisourceBergen has demonstrated consistent capability to meet competitive procurement requirements across multiple therapeutic domains through its extensive portfolio of delivery orders with the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/17/25 |